Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult life.

Bamford, A, Turkova, A, Lyall, H, Foster, C, Klein, N, Bastiaans, D, Burger, D, Bernadi, S, Butler, K, Chiappini, E, Clayden, P, Della Negra, M, Giacomet, V, Giaquinto, C, Gibb, D, Galli, L, Hainaut, M, Koros, M, Marques, L, Nastouli, E, Niehues, T, Noguera-Julian, A, Rojo, P, Rudin, C, Scherpbier, H J, Tudor-Williams, G and Welch, S B (2018) Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult life. HIV medicine, 19 (1). e1-e42. ISSN 1468-1293. This article is available to all HEFT staff and students via ASK Discovery tool http://tinyurl.com/z795c8c by using their HEFT Athens login IDs

Full text not available from this repository.
Official URL: https://onlinelibrary.wiley.com/doi/10.1111/hiv.12...

Abstract

The 2015 Paediatric European Network for Treatment of AIDS (PENTA) guidelines provide practical recommendations on the management of HIV-1 infection in children in Europe and are an update to those published in 2009. Aims of treatment have progressed significantly over the last decade, moving far beyond limitation of short-term morbidity and mortality to optimizing health status for adult life and minimizing the impact of chronic HIV infection on immune system development and health in general. Additionally, there is a greater need for increased awareness and minimization of long-term drug toxicity. The main updates to the previous guidelines include: an increase in the number of indications for antiretroviral therapy (ART) at all ages (higher CD4 thresholds for consideration of ART initiation and additional clinical indications), revised guidance on first- and second-line ART recommendations, including more recently available drug classes, expanded guidance on management of coinfections (including tuberculosis, hepatitis B and hepatitis C) and additional emphasis on the needs of adolescents as they approach transition to adult services. There is a new section on the current ART 'pipeline' of drug development, a comprehensive summary table of currently recommended ART with dosing recommendations. Differences between PENTA and current US and World Health Organization guidelines are highlighted and explained.

Item Type: Article
Additional Information: This article is available to all HEFT staff and students via ASK Discovery tool http://tinyurl.com/z795c8c by using their HEFT Athens login IDs
Subjects: WS Paediatrics. Child health
Divisions: Womens and Childrens > Paediatrics
Related URLs:
Depositing User: Mrs Semanti Chakraborty
Date Deposited: 16 Jul 2018 15:54
Last Modified: 16 Jul 2018 15:54
URI: http://www.repository.uhblibrary.co.uk/id/eprint/1699

Actions (login required)

View Item View Item